We're pleased to announce that 1000 patients have been enrolled in the FREEDOM Lumbar Microdiscectomy Registry designed to understand the prevalence of large annular defects. 55 investigators have finalized enrollment at their sites, and many more are nearing completion. A special thanks to all our clinical investigators for gathering this invaluable data that may help identify those patients at highest risk for reoperation for reherniation. For full benefit-risk information, please visit https://hubs.ly/Q02Z5Kvr0 #spine #medtech #spinesurgery #spinehealth #spinesurgeon #medicine #healthcare #discectomy #microdiscectomy #discherniation
Intrinsic Therapeutics, Inc
医疗设备制造业
Woburn，MA 4,028 位关注者
Manufacturer of Barricaid? Designed to prevent reherniation.
关于我们
Adjacent to a lumbar discectomy, the Barricaid? device is designed to close large defects in the annulus, which often lead to disc reherniation and/or disc collapse. Barricaid is a permanent implant with two components - a titanium bone anchor and a flexible polymer barrier. The barrier is designed to prevent reherniation by physically blocking the annulus at the post-surgery defect. The anchor component is comprised of titanium alloy that is placed into either the caudal or cranial-adjacent vertebral body to secure the device in position. The Barricaid has been studied in a definitive – level 1B evidence - randomized superiority trial with over 550 patients enrolled (clinicaltrials.gov NCT01283438). The study focuses on patient at highest risk of reherniation and reoperation, enrolling only those patients with large defects (width >5 mm). The co-primary endpoints of reherniation and an 8-point composite of safety and effectiveness are evaluated at 2 years, with a parallel cost effectiveness analysis. Treated patients were found superior on both endpoints, with significantly lower rates of symptomatic recurrences (12% vs. 25%, p<0.001), index-level reoperations (9% vs. 16%, p=0.01), and device or procedure related serious adverse events (SAEs) (7% vs. 17%, p=0.001). Through two years, a total of 29 reoperations were performed in Barricaid subjects in comparison to 61 procedures in Controls. Study results are published in The Spine Journal, May 2018. Barricaid is FDA-Approved For full risk/benefit, see: www.barricaid.com/instructions-for-use
- 网站
-
https://www.barricaid.com
Intrinsic Therapeutics, Inc的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Woburn，MA
- 类型
- 上市公司
- 创立
- 2000
地点
Intrinsic Therapeutics, Inc员工
动态
-
Congratulations to Dr. David Eng, MD, PhD at Crouse Hospital in Syracuse, NY on recently performing his 1st Barricaid procedure! Thanks to Dr. Eng implanting Barricaid and helping this 47-year-old patient reduce their risk of reoperation for reherniation by 81%. Thank you to Dr. Eng for your commitment to improving outcomes for your discectomy patients. Thank you to David J. Christopher Christopher, Glenn Sanders, Timothy Ko, PA-C, MS-PAS, RDMS for supporting the case! For full benefit-risk information, please visit https://hubs.ly/Q02XTQ9-0 #spine #medtech #spinesurgery #spinehealth #spinesurgeon #medicine #healthcare #discectomy #microdiscectomy #discherniation
-
-
Join Barricaid for the Medical Device Manufacturers Association Reimbursement & Health Policy Conference at the Office of Hogan Lovells in Washington, DC Nov. 13 - 14. For full benefit-risk information, please visit https://hubs.ly/Q02XTNCy0 #spine #medtech #spinesurgery #spinehealth #spinesurgeon #medicine #healthcare #discectomy #microdiscectomy #discherniation
-
-
FOR IMMEDIATE RELEASE: Intrinsic Therapeutics Announces Changes in CMS’ 2025 Final Rule for Bone Anchored Annular Closure Resulting in Improved Payment for Hospital Outpatient and ASCs. The Final Rule updated the Medicare payment rate for HCPCS procedure code C9757, created specifically to describe a lumbar discectomy with repair of annular defect using the Barricaid Bone Anchored Annular Closure implant, from $6,500.62 to $9,527.15 in the Ambulatory Surgery Center (ASC), an increase of 46%. “We are gratified by CMS’ evaluation of a complex series of facts to arrive at this decision. More patients around the country will now have access to the proven Barricaid treatment”, commented April Spillane, VP of Health Economics at Intrinsic Therapeutics. Dr. Paul Kraemer, Orthopedic Surgeon at Indiana Spine Group had this to say on the decision, "Patients deserve the opportunity to make their first spine surgery their last spine surgery. This decision will help make it economically feasible for surgeons and facilities to offer the Barricaid procedure." Read the full press release here: https://hubs.ly/Q02XVgVN0 #spine #medtech #spinesurgery #spinehealth #spinesurgeon #medicine #healthcare #discectomy #microdiscectomy #discherniation
-
-
At Intrinsic Therapeutics, we believe that surgical decisions should be made by surgeons, NOT insurance companies. The Barricaid Patient First Program puts the clinical decision back into the hands of the surgeon by mitigating nonpayment concerns with commercial payors.? ? Dr. Jeffrey Henn discusses his experience with the Patient First Program, "Patient First has been game changing for us...we know we're going to be able to move forward (with surgery regardless of prior authorization outcome) and do the right thing for the patient..."? ? Interested in learning more? Reach out to your local territory manager to discuss. #spine #medtech #spinesurgery #spinehealth #spinesurgeon #medicine #healthcare #discectomy #microdiscectomy #discherniation
-
Congratulations to Dr. Larry Parker at Huntsville Hospital in Huntsville, AL on recently performing his 10th Barricaid procedure! Thanks to Dr. Parker implanting Barricaid and helping this 54-year-old patient reduce their risk of reoperation for reherniation by 81%. Thank you to Dr. Parker for your commitment to improving outcomes for your discectomy patients. Thank you to John Godwin and Michael Jordan, PA for supporting the case! For full benefit-risk information, please visit https://hubs.ly/Q02X9k270 #spine #medtech #spinesurgery #spinehealth #spinesurgeon #medicine #healthcare #discectomy #microdiscectomy #discherniation
-
-
Congratulations to Dr. Sean Barber at Houston Methodist in Houston, TX on recently performing his 1st Barricaid procedure! Thanks to Dr. Barber implanting Barricaid and helping this 38 year-old patient reduce their risk of reoperation for reherniation by 81%. Thank you to Dr. Barber for your commitment to improving outcomes for your discectomy patients. Thank you to Steve Belter and Lauren Culver, MD for supporting the case! For full benefit-risk information, please visit https://hubs.ly/Q02WPbWG0 #spine #medtech #spinesurgery #spinehealth #spinesurgeon #medicine #healthcare #discectomy #microdiscectomy #discherniation
-
-
Congratulations to our amazing Health Economics and Patient Journey Team for reaching their 2,000-patient milestone advocating for patients! The Barricaid Patient Journey Team's mission is to complete authorization and appeals (as necessary) for all patients and educate them throughout their journey. For full benefit-risk information, please visit https://hubs.ly/Q02WD-w40 . . . #spine #medtech #spinesurgery #spinehealth #spinesurgeon #medicine #healthcare #discectomy #microdiscectomy #discherniation #patientadvocacy
-
-
We are thrilled to announce there have now been 500 Barricaid patients treated in the state of Texas! Congratulations and thank you to all of our Barricaid-trained surgeons and APPs in Texas on reaching this milestone and helping to reduce the needless suffering caused by recurrent disc reherniation. To our talented Texas team (Steve Belter, Allison Merkel, Mike Moran, and Koby Rogers), thank you for your continued dedication to your surgeons and their patients! For full benefit-risk information, please visit https://hubs.ly/Q02Ww4kX0 #barricaid #spine #medtech #spinesurgery #spinehealth #spinesurgeon #medicine #healthcare #discectomy #microdiscectomy #discherniation #txhealthcare
-
-
The #Barricaid Woburn HQ team is heading into the weekend celebrating the recent Category 1 CPT code approval announcement (https://hubs.ly/Q02VVTrd0)! A huge thank you to our amazing team, both locally and across the country, for your unwavering dedication to supporting healthcare professionals and their patients. Together, we will continue our mission to reduce needless suffering by ensuring Barricaid is accessible to both patients and surgeons! #spine #cptcode #medtech #spinesurgery #spinehealth #spinesurgeon #medicine #healthcare #discectomy #microdiscectomy #discherniation
-